Dermapharm Holding (Germany) Price Prediction
| DMP Stock | 37.80 0.20 0.53% |
Oversold Vs Overbought
62
Oversold | Overbought |
Using Dermapharm Holding hype-based prediction, you can estimate the value of Dermapharm Holding SE from the perspective of Dermapharm Holding response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Dermapharm Holding to buy its stock at a price that has no basis in reality. In that case, they are not buying Dermapharm because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Dermapharm Holding after-hype prediction price | EUR 37.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Dermapharm |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dermapharm Holding's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dermapharm Holding After-Hype Price Prediction Density Analysis
As far as predicting the price of Dermapharm Holding at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dermapharm Holding or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Dermapharm Holding, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Dermapharm Holding Estimiated After-Hype Price Volatility
In the context of predicting Dermapharm Holding's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dermapharm Holding's historical news coverage. Dermapharm Holding's after-hype downside and upside margins for the prediction period are 35.80 and 39.80, respectively. We have considered Dermapharm Holding's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Dermapharm Holding is very steady at this time. Analysis and calculation of next after-hype price of Dermapharm Holding is based on 3 months time horizon.
Dermapharm Holding Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Dermapharm Holding is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dermapharm Holding backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dermapharm Holding, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 2.01 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
37.80 | 37.80 | 0.00 |
|
Dermapharm Holding Hype Timeline
Dermapharm Holding is currently traded for 37.80on XETRA Stock Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Dermapharm is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.14%. %. The volatility of related hype on Dermapharm Holding is about 0.0%, with the expected price after the next announcement by competition of 37.80. About 65.0% of the company shares are held by company insiders. The book value of Dermapharm Holding was currently reported as 9.36. The company last dividend was issued on the 2nd of June 2022. Assuming the 90 days trading horizon the next projected press release will be in a few days. Check out Dermapharm Holding Basic Forecasting Models to cross-verify your projections.Dermapharm Holding Related Hype Analysis
Having access to credible news sources related to Dermapharm Holding's direct competition is more important than ever and may enhance your ability to predict Dermapharm Holding's future price movements. Getting to know how Dermapharm Holding's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dermapharm Holding may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRK | Merck KGaA | 0.00 | 0 per month | 0.00 | (0.14) | 2.08 | (2.09) | 10.92 | |
| H6D | Haleon PLC | 0.00 | 0 per month | 1.49 | (0.02) | 2.84 | (2.34) | 8.17 | |
| LP6 | LIVZON PHARMAC GRP | 0.00 | 0 per month | 2.31 | 0.11 | 5.59 | (2.58) | 20.56 | |
| S2P | SIMCERE PHARMAC GRP | 0.00 | 0 per month | 2.48 | 0.07 | 5.13 | (3.85) | 18.98 | |
| CJH | CanSino Biologics | 0.00 | 0 per month | 3.56 | 0.14 | 13.07 | (5.82) | 30.83 | |
| EVT | Evotec SE | 0.00 | 0 per month | 4.65 | 0.12 | 9.76 | (8.38) | 36.91 | |
| DMP | Dermapharm Holding SE | 0.00 | 0 per month | 1.31 | 0.08 | 3.97 | (2.35) | 10.99 | |
| BSFA | ANI Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.04) | 3.41 | (3.30) | 9.18 | |
| R2WA | BEXIMCO PHARMAGDR REGS | 0.00 | 0 per month | 2.28 | 0.23 | 6.45 | (4.00) | 32.13 |
Dermapharm Holding Additional Predictive Modules
Most predictive techniques to examine Dermapharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dermapharm using various technical indicators. When you analyze Dermapharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Dermapharm Holding Predictive Indicators
The successful prediction of Dermapharm Holding stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Dermapharm Holding SE, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Dermapharm Holding based on analysis of Dermapharm Holding hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Dermapharm Holding's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Dermapharm Holding's related companies.
Story Coverage note for Dermapharm Holding
The number of cover stories for Dermapharm Holding depends on current market conditions and Dermapharm Holding's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dermapharm Holding is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dermapharm Holding's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Dermapharm Holding Short Properties
Dermapharm Holding's future price predictability will typically decrease when Dermapharm Holding's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dermapharm Holding SE often depends not only on the future outlook of the potential Dermapharm Holding's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dermapharm Holding's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.8 M | |
| Cash And Short Term Investments | 173.2 M |
Additional Tools for Dermapharm Stock Analysis
When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.